These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
356 related articles for article (PubMed ID: 4193011)
1. [Blood group incompatibility in the ABO and Rh(D) systems in women with a blood transfusion anamnesis]. Dzierzkowa-Borodej W; Olearczyk J Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(3):341-3. PubMed ID: 4193011 [No Abstract] [Full Text] [Related]
2. Transfusion support in the management of immune haemolytic disorders. Plapp FV; Beck ML Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130 [No Abstract] [Full Text] [Related]
3. [Aspects of ABO blood group incompatibility in the pre- and postnatal periods]. Novachev D; Markov L Akush Ginekol (Sofiia); 1980; 19(4):322-8. PubMed ID: 6774626 [No Abstract] [Full Text] [Related]
4. ABO protection in Rh immunization. Nevanlinna HR Ann Med Exp Biol Fenn; 1966; 44(2):318-21. PubMed ID: 4961011 [No Abstract] [Full Text] [Related]
5. Current clinical concepts in hemolytic disease and blood group incompatibility. Cherry SH Prog Clin Biol Res; 1981; 70():205-12. PubMed ID: 6273933 [No Abstract] [Full Text] [Related]
6. Some factors influencing Rh immunization during pregnancy. Cooke BR; Bradley MA; Walsh RJ Med J Aust; 1965 Sep; 2(11):437-41. PubMed ID: 4953260 [No Abstract] [Full Text] [Related]
7. [Materno-fetal incompatibility in the ABO system as a factor of protection against hemolytic disease caused by Rh incompatibility]. Mollica F Minerva Pediatr; 1967 Mar; 19(13):610-1. PubMed ID: 4963996 [No Abstract] [Full Text] [Related]
8. The prevention of rhesus-isoimmunization. Davey M Clin Obstet Gynaecol; 1979 Dec; 6(3):509-30. PubMed ID: 92385 [No Abstract] [Full Text] [Related]
9. [Immunological changes after massive blood transfusion (review of the literature)]. Margulis MS; Grisle GP Khirurgiia (Mosk); 1986 Sep; (9):138-41. PubMed ID: 3099053 [No Abstract] [Full Text] [Related]
10. [Maternal-fetal blood group incompatibility in the light of recent statistical and immunohematological data]. Ragonese P; Rizzo F; Ricevuto C; D'Angelo S; Liotti B Minerva Ginecol; 1976 Jan; 28(1):26-30. PubMed ID: 815851 [No Abstract] [Full Text] [Related]
11. Do we need to be more concerned about weak D antigens? Garratty G Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202 [No Abstract] [Full Text] [Related]
12. [Immunogenic role of previous Rh-incompatible transfusion in hemolytic disease of the newborn]. Ilieva V Akush Ginekol (Sofiia); 1965; 4(5):481-5. PubMed ID: 4956858 [No Abstract] [Full Text] [Related]
13. [Anti-D treatment after mismatched transfusion: prevention of Rh sensitization]. Schellong G; Grimm W Dtsch Med Wochenschr; 1970 Dec; 95(51):2555-9. PubMed ID: 4998366 [No Abstract] [Full Text] [Related]
14. [Simultaneous hemolytic diseases in mother and child resulting from a rare form of isoimmunization]. JoĆ³-Szabados T; Kun E; Hervei S Orv Hetil; 1977 Mar; 118(13):757-9. PubMed ID: 403497 [No Abstract] [Full Text] [Related]
16. [Remote after-effects of hemolytic diseases in newborn, caused by the ABO- and Rh-incompatibility in the blood of mother and fetus]. Nersisian VM Zh Eksp Klin Med; 1969; 9(5):82-5. PubMed ID: 4988140 [No Abstract] [Full Text] [Related]
17. [Rh and ABO incompatibility]. Brandl K Wien Klin Wochenschr; 1965 Oct; 77(42):814-5. PubMed ID: 4956671 [No Abstract] [Full Text] [Related]
18. [Letter: Fetomaternal blood incompatibilities in Rh positive women]. Senecal J; Le Marec B; Genetet B; Bonnefoy O; Le Freche J Nouv Presse Med; 1976 May; 5(18):1211. PubMed ID: 818622 [No Abstract] [Full Text] [Related]
20. [Incidence of irregular antibodies found in patients and in pregnancy tests]. Busch H; Rothe B von E; Hochweller E Munch Med Wochenschr; 1970 Feb; 112(8):341-51. PubMed ID: 4997704 [No Abstract] [Full Text] [Related] [Next] [New Search]